Company Profiles

driven by the PitchBook Platform

Avaxia

Description

Developer of orally delivered antibody therapeutics designed to act locally in the gastrointestinal tract. The company's orally delivered antibody therapeutics are unique because they are taken orally this allows the antibodies to act locally on biological targets that are present in the GI track, targets include soluble proteins and cell-bound proteins, enabling patients with inflammatory bowel disease, diabetes and obesity to improve treatment.

2005

Founded

M&A

Status

11-50

Employees

M&A

Latest Deal Type

$23.7M

Total Amount Raised

1

Investors

Description

Developer of orally delivered antibody therapeutics designed to act locally in the gastrointestinal tract. The company's orally delivered antibody therapeutics are unique because they are taken orally this allows the antibodies to act locally on biological targets that are present in the GI track, targets include soluble proteins and cell-bound proteins, enabling patients with inflammatory bowel disease, diabetes and obesity to improve treatment.

Website:

www.avaxiabiologics.com

Ownership Status

Acquired/Merged

Financing Status

Formerly VC-Backed

Primary Industry

Drug Delivery

Other Industries

Biotechnology

Primary Office

128 Spring Street Suite 620 Lexington, MA 02421United States +1 (781) 861-0062
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Avaxia's full profile, request a free trial.

Avaxia Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Avaxia Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Avaxia Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Keiretsu ForumVenture CapitalMinority000 0000000 0000
Keiretsu Forum Venture Capital

Avaxia Executive Team (4)

NameTitleBoard
Seat
Contact
Info
David Poorvin Ph.DCo-Founder & Board Member
Neil Schauer Ph.DSenior Vice President, Technical Operations
Michael RivardVice President, Corporate Development
Barbara Fox Ph.DCo-Founder, Chief Executive Officer & Board Member
David Poorvin Ph.D Co-Founder & Board Member
Neil Schauer Ph.D Senior Vice President, Technical Operations
Michael Rivard Vice President, Corporate Development
Barbara Fox Ph.D Co-Founder, Chief Executive Officer & Board Member

Avaxia Board Members (2)

NameRepresentingRoleSinceContact
Info
Barbara Fox Ph.DSelfCo-Founder, Chief Executive Officer & Board Member000 0000
David Poorvin Ph.DAvaxiaCo-Founder & Board Member000 0000
Barbara Fox Ph.D Co-Founder, Chief Executive Officer & Board Member Self
David Poorvin Ph.D Co-Founder & Board Member Avaxia
Request full access to PitchBook